Correlation Between Jazz Pharmaceuticals and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Jazz Pharmaceuticals and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jazz Pharmaceuticals and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jazz Pharmaceuticals PLC and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Jazz Pharmaceuticals and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jazz Pharmaceuticals with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jazz Pharmaceuticals and Apellis Pharmaceuticals.
Diversification Opportunities for Jazz Pharmaceuticals and Apellis Pharmaceuticals
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Jazz and Apellis is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Jazz Pharmaceuticals PLC and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Jazz Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jazz Pharmaceuticals PLC are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Jazz Pharmaceuticals i.e., Jazz Pharmaceuticals and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Jazz Pharmaceuticals and Apellis Pharmaceuticals
Given the investment horizon of 90 days Jazz Pharmaceuticals PLC is expected to generate 0.21 times more return on investment than Apellis Pharmaceuticals. However, Jazz Pharmaceuticals PLC is 4.69 times less risky than Apellis Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest 12,254 in Jazz Pharmaceuticals PLC on November 8, 2024 and sell it today you would lose (247.00) from holding Jazz Pharmaceuticals PLC or give up 2.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Jazz Pharmaceuticals PLC vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Jazz Pharmaceuticals PLC |
| Apellis Pharmaceuticals |
Jazz Pharmaceuticals and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Jazz Pharmaceuticals and Apellis Pharmaceuticals
The main advantage of trading using opposite Jazz Pharmaceuticals and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jazz Pharmaceuticals position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Jazz Pharmaceuticals vs. Incyte | Jazz Pharmaceuticals vs. Alnylam Pharmaceuticals | Jazz Pharmaceuticals vs. United Therapeutics | Jazz Pharmaceuticals vs. Ultragenyx |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |